Scientific Programme for the 19th International Leprosy Congress, Beijing 2016

Leprosy Mailing List – February 2,  2016

Ref.:    (LML)  Scientific Programme for the 19^th International Leprosy Congress, Beijing 2016

From:  Cairns Smit, Aberdeen, UK

---

Dear Colleagues,

                 This is a message about the details of the Congress Scientific Programme for the 19^th International Leprosy Congress, Beijing 2016. 

                  We have developed a comprehensive programme of plenary sessions with leading experts – see below.

                  There will also be a series of Workshops and Congress sessions – see below.

On behalf of the Congress Scientific committee,

Cairns Smith

Confirmed Plenary Sessions – 19^th ILC

Inaugural session – organised by the China Organising Committee (I hour

- Ministers

- ILA President

- WHO Representative

- LEP President

- Novartis Foundation-

- Nippon Foundation

- China Association of People affected by leprosy

- Special Presentation: 60 years of leprosy control in China – Professor Zhang Guocheng

- Special Keynote Lecture:  Recent advances in research relevant to leprosy – to be confirmed

Plenary 1:  A Global strategy for leprosy fit for purpose (1.5 hours)

Chair:  Marcos Virmond (ILA President, Brazil)

WHO Global Strategy for Leprosy 2016-2020: accelerating towards a leprosy-free world – Drs Erwin Cooreman and Laura Gillini (25 minutes)

Discussants:    Fit for national government (India)

   Fit with national government (Brazil) - Rosa Castalia

                        Fit with NGOs – Tanya Wood (ILEP)

                        Fit with needs of people affected leprosy – To be confirmed

                        Fit with NTDs – Emmy van der Grinten (Ghana)         

Moderated Discussion: 30 minutes

Plenary 2: Innovations to reduce transmission (1.5hours)

Chair: Ann Aerts (Novartis Foundation)

-       What will U-MDT contribute to leprosy control? (JH Kawuma - Uganda)

-       The potential of chemoprophylaxis to reduce transmission (Peter Steinmann - Switzerland)

-       Can new diagnostic test improve control of leprosy?   (Fareed Mirza – Switzerland)

-       Can novel vaccines become a reality? (Steve Reed - USA)

Moderated Discussion (30 minutes)

Plenary 3: Advances in clinical management of leprosy

Chair: Shyamala Anand – Clinical Ophthalmologist (India)

Understanding the pathology of nerve injury in leprosy - Sergio L Antunes (Brazil)

Advances in dermatological aspects of leprosy – Fu Ren Zhang (China) 

Advances in the treatment of reactions – Diana Lockwood (UK)

Integrated preventing disability across NTDs – Linda Lehman (Brazil)

Moderated Discussion (30 minutes)

Plenary 4:  Promoting inclusion of people affected by leprosy

Chair: Anwei Law (USA)

-       Sociological aspects of barriers and facilitators to inclusion - Cassandra White (USA)

-       Evidence for interventions to reduce stigma- Ruth Peters (Indonesia)

-       Enabling participation of people affected by leprosy - Michael Chen (HANDA, China)

-       Making a difference to policy and practice – Matthias Duck (Paraguay)

Moderated Discussion (30 minutes)

Workshops and Parallel Sessions

Workshops 

1.       Definition of leprosy – sub-clinical and clinical (David Scollard, USA/Claudio Salgado, Brazil)

2.       ENL reactions (Steve Walker - UK)

3.       U-MDT (Gerson Penna - Brazil)

4.       Chemoprophylaxis pilot studies (Bart vender Plaetse - Switzerland)

5.       Diagnostic tests (Annemeike Geluk - Netherlands)

6.       Changing discriminatory legislation (Sunil Anand - India)

7.       Drug resistance (Emanuelle Cambau - France)

8.       Clinical Problems Panel (Ben Naafs - Netherlands)

9.       History of leprosy update (Jo Robertson - Australia)

10.   Molecular biology and genetics (Milton Moraes - Brazil)

11.   GIS and Mapping (Paul Saunderson - Norway)

12.   Enabling enhanced participation (Hiroe Soyagimi - Japan)

13.   Early detection and transmission (Tom Gillis LRI 1 - USA)

14.   Disability and reactions (William Faber LRI 2 - Netherlands)

15.   Inclusion research (Wim van Brakel LRI 3 - Netherland)

16.   Data systems and new indicators for monitoring the global strategy. (Laura Gillini - India)

17.   Molecular biology and Genetics (U Gupta, JALMA - India)

18.   Epidemiological issues in preventing new disease occurrence (Chair – SK Noordeen, India)

19.   Leprosy control in francophone Africa (Chair: Christian Johnson, Benin)

Congress Sessions

1.       Best clinical practice, health systems, training and referral

2.       Chemotherapy

3.       Reactions and nerve injury

4.       Dermatology

5.       Ophthalmology

6.       History

7.       Human rights and Discrimination

8.       Social aspects

9.       Participation

10.   Immunology and vaccines

11.   Microbiology

12.   Molecular biology and Genetics 

13.   Epidemiology

14.   Leprosy Control

15.   Prevention – prophylaxis

16.   Transmission and diagnostics

17.   Neglected Tropical Diseases and other mycobacterial diseases

18.   Nerve function and impairments

19.   Prevention of disability

20.   Rehabilitation

---

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com